The Study Aimed To See If Adding Zinc Acetate To Triamcinalone Acetonide Would Help To Treat Patients With Oral Lichen Planus

Assessment of efficacy of zinc acetate as an adjuvant to triamcinalone acetonide in patients with oral lichen planus: A randomized clinical trail. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073385

Enrollment

Registered

2024-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Zinc Acetate: TAB. Zinc Acetate 15MG Twice a day for two months will be given for the patients Control Intervention1: Triamcinolone Acetonide: Ointment Triamcinolone Acetonide twice a

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Symptomatic Oral Lichen Planus Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients with Asymptomatic Oral Lichen Planus Pregnant and lactating females Patient with history of CNS, CVS, Renal or Hepatic diseases except hypertension Patients with Cancers Patients under active treatment for lichen planus Patients on steroids, immunomodulators for other conditions

Design outcomes

Primary

Measure	Time frame
PAIN SCORE USING VISUAL ANALOUGE SCALETimepoint: 1ST,7TH,14TH,21ST	—

Secondary

Measure	Time frame
PAIN SCORE USING THONGPRASOM SCALETimepoint: 1ST,7H,14TH,21ST	—

Countries

India

Contacts

Public ContactSurasura venkata padmini

NARAYANA DENTAL COLLEGE AND HOSPITAL

chikkipaddu96@gmail.com9441788440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026